ロード中...
An argument for broad use of high efficacy treatments in early multiple sclerosis
Two different treatment paradigms are most often used in multiple sclerosis (MS). An escalation or induction approach is considered when treating a patient early in the disease course. An escalator prioritizes safety, whereas an inducer would favor efficacy. Our understanding of MS pathophysiology h...
保存先:
| 出版年: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6935832/ https://ncbi.nlm.nih.gov/pubmed/31757815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000636 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|